GFAP and obstructive sleep apnea syndrome: Previous studies have demonstrated a correlation between serum levels of GFAP and objective sleep quality in individuals diagnosed with chronic insomnia disorder (Kong et al., 2021), and serum GFAP levels may serve as a biomarker for assessing disease severity in patients with OSA (Guzel and Salış, 2024).